IMV Inc. (IMV) Announces Board Changes

Go back to IMV Inc. (IMV) Announces Board Changes

IMV Inc. Announces Changes to Its Board of Directors

March 27, 2023 4:15 PM UTC

DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies, based on its novel DPX platform, to treat solid and hematologic cancers, today announced changes to its board of directors as Shermaine Tilley, Ph.D., MBA has resigned from the Board of Directors ("Board") of the Company, effective immediately.

Dr. Tilley, Managing Partner at CTI Life Sciences Fund (CTI LSF), was originally appointed to the IMV Board in 2016 as a representative from CTI LSF following their initial investment in... More